Genital self-sampling for HPV-based cervical cancer screening: a qualitative study of preferences and barriers in rural Ethiopia by Brandt, Theresa et al.
RESEARCH ARTICLE Open Access
Genital self-sampling for HPV-based
cervical cancer screening: a qualitative
study of preferences and barriers in rural
Ethiopia
Theresa Brandt1* , Solomon Berhe Wubneh2, Simegnew Handebo3, Getu Debalkie3, Yohanes Ayanaw3,
Kassahun Alemu3,4, Felix Jede1, Magnus von Knebel Doeberitz1 and Hermann Bussmann1
Abstract
Background: In the context of WHO’s “task shifting” project and growing global consensus on primary HPV-based
cervical cancer screening, self-sampling is a promising new tool to expand screening access, uptake and coverage
for women worldwide. We aimed to explore perceptions and acceptability of HPV self-sampling-based
cervical cancer screening among community members and health professionals in rural northwest Ethiopia
and to identify preferences and socio-cultural barriers regarding self-sampling in order to design a suitable
high-coverage screening intervention for a rural African setting.
Methods: Four community-based focus group discussions (FGD) were conducted in the rural district of
Dabat, Northwest Ethiopia, each comprising 8 to 14 female participants, counting a total of 41 participants.
The groups were homogenously composed in terms of their socio-economic status in the community. They
included health centre attendees, community members, nurses and health development army leaders (HDAL). Two
qualitative data collection experts conducted the interviews in the local language, using a FGD guide with several
thematic areas. All participants granted written informed consent prior to the conduct of the interviews. As a concrete
example of an existing self-sampling approach for cervical cancer screening we used the Evalyn® Brush.
Results: Emerging themes included (i) misconceptions and low awareness about cervical cancer among community
residents and primary health care providers in rural northwest Ethiopia, (ii) stigmatization and social exclusion of
affected women, (iii) delay in seeking of health care due to poor access and availability of services, and lacking of a
concept of early cancer prevention, (iv) need of spousal permission, (v) fear of financial burden and (vi) fear of social
marginalization. The self-sampling device was regarded to be acceptable and was judged to be easy to use for most
women. The existing Ethiopian health care structure could facilitate a community approach.
Conclusion: Home-based self-sampling for cervical cancer screening is a socially acceptable and feasible “task shifting”
method that will increase cervical cancer screening access and coverage in the Ethiopian study community. Education,
awareness creation, community mobilization and family inclusion are identified as key activities to promote, implement
and facilitate “task shifting” approaches like self-sampling.
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Background
Cervical cancer remains one of the most common female
cancers in low-resource settings [1] although highly pre-
ventable as shown in countries with functional screening
programs [2–4]. Many obstacles hinder a successful fight
against cancer in poor, rural and remote areas of the world
including the unavailability or inefficacy of screening pro-
grams, underfunded and overburdened health services
and high prevalence of HPV and HIV infections.
In 2006, the World Health Organization (WHO), in
collaboration with the Office of the United States Global
AIDS Coordinator (OGAC), has launched the WHO/
OGAC Task Shifting Project. “Task shifting” is the
delegation of responsibilities to less specialized health
workers making more efficient use of limited medical
personnel in LMIC (low and middle-income countries).
It has been successfully implemented in HIV treatment
and prevention, for instance qualified community
workers delivering a wide range of HIV services, as a
result freeing time of nurses and doctors [5–7].
Despite available vaccines against HPV infections,
screening programs and preventive examinations will
continue to play an important role in early cancer de-
tection for all non-vaccinated, but also HPV vacci-
nated women all around the world. Regarding cervical
cancer, HPV testing is considered the most effective
screening approach combining high sensitivity with
high negative predictive value [8–11]. The absence of
a high risk (hr)HPV infection ensures low cancer risk
for a considerable time period of at least 5–7 years as
a persistent infection is needed for the development
of cervical cancer [12–15].
Self-collection of genital samples for (hr)HPV DNA
analysis are opening new ways for “task shifting” away
from the few, centralized and remote health centres and
clinics into the rural communities themselves. They have
shown to perform equally well compared to provider-
collected samples [16–20]. In Europe self-sampling is
being increasingly tested in well-established programs as
a means to engage screening defaulters e.g. by sending a
self-sampling kit by post [21–27]. In a number of low
resource settings high acceptance of self-sampling has
been reported from studies done among women attend-
ing health facilities [28–33]. But only a few studies have
also looked at women’s characteristics including socio-
economic status, cultural background and prior know-
ledge and experience of cervical cancer screening [34–37].
The use of self-sampling as a home-based method to
increase screening access and to relieve overburdened and
understaffed health services will potentially face different
challenges including knowledge, understanding, willing-
ness, privacy, and socio-cultural issues.
Among Ethiopian women, cervical cancer is ranked
second most common female cancer and second leading
cause of cancer death [1, 38]. The vulnerable female
population comprises 31.5 million women [39] making it
a reproductive and maternal health issue of unique rele-
vance. The Ethiopian government just recently launched
a HPV vaccination program for 14-year-old girls and
also started introducing visual inspection with acetic
acid (VIA). However, over 80% of the population lives in
rural areas of the country, leaving only 0.6% of all
women with access to opportunistic rather than regular
cervical cancer screening [39]. Hence, the impact of
these recently established programs will take time.
Home-based HPV-testing could therefore be a promis-
ing approach to initiate population-based screening pro-
grams. This is the first qualitative study to explore
perceptions, acceptability, barriers and preferences of
HPV self-sampling in a rural Ethiopian community naïve
to screening practices in order to design a high-coverage
cervical cancer screening intervention.
Methods
Study design
We undertook a qualitative study using community
Focus Group Discussions (FGDs) and Key Informant In-
terviews (KIIs) to explore community members’ and
health professionals’ knowledge about cervical cancer, as
well as perceptions and acceptability of HPV self-sam-
pling. In the health sector, FGDs are a popular method
benefiting from particular group dynamics and interac-
tions when generating data exploring knowledge, mo-
tives and experiences. However, when aiming to gather
sensitive information KIIs can add qualitative depth as
they are conducted in a one-on-one setting creating a
more intimate and confidential environment in which
potentially sensitive information can be shared without
fear of repercussions [40, 41].
Through the FGDs and KIIs we aimed to identify
specific preferences and socio-cultural barriers of the
community concerning this cervical cancer screening
approach to identify the best form for the function of
HPV self-sampling and, thus, to design a suitable
intervention for this rural African setting. Ethical
approval was obtained from the Institutional Review
Board (IRB) of the University of Gondar, as well as
the IRB at Heidelberg University School of Medicine,
Germany. All participants were provided with infor-
mation about the study, were willing to participate
and signed an Informed Consent Form in Amharic
prior to the conduct of the interview.
Setting
The study was conducted in the Dabat Health Centre in
June 2017. The Dabat district in the Amharic region of
Ethiopia contains 30 mainly rural communities (kebele)
with each a population of approximately 5000 people.
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Families typically live as subsistence farmers on their
homestead surrounded by small fields where they grow
crops and herd their livestock. Each kebele has a health
post staffed with community health extension workers
(CHEW) responsible for health promotion and disease
prevention in their communities. They closely work
together with designated female residents of the kebele,
the so called Health Development Army Leaders
(HDAL), who have better insight, as well as influence on
the households, health behaviour and habits of their
“gotes” (smaller organised groups of the community).
Data collection
All sexually active women between the ages of 20 and 65
years, permanently living in Dabat Town who were capable
to understand the study procedures and were willing to vol-
untarily participate were eligible to enrol in the study. Sat-
uration was reached after the conduct of four community
FGDs with a total of 41 female participants, as well as four
KIIs. FGD participants (see Additional file 1: Table S1) and
key informants (see Additional file 2: Table S2) were identi-
fied opportunistically from the target community, as well as
the local health service program. Two male qualitative data
collection experts (researchers of health education and
behavioural sciences and lecturers at the Public Health
Institute at Gondar University, with a master’s degree in
health education and behavioural science) lead and con-
ducted the FGDs. The focus group (FG) topic guide was
written in English and translated into the local language –
Amharic – prior to the conduct of the FGDs. It was
designed to gather information on knowledge and local
perceptions of cervical cancer and women affected by it,
knowledge about available preventive methods, possible fa-
cilitators and barriers for preventive screening, particularly
in regard to the self-sampling device, the Evalyn® Brush and
recommendations for implementation of a pilot screening
study. Key topics were probed in each focus group (see
Additional file 4).
The Evalyn® Brush was chosen as a concrete example
of self-sampling technology because in previous studies
it was well accepted by women; they found it comfort-
able and easy to use [17, 42–44]. Furthermore, it was
shown to have a low inadequate specimen rate [17], as
well as very good agreement with provider-taken speci-
mens [17, 42, 44–46]. It can be stored dry at room
temperature for transport [17, 42, 46] and can last up to
32 weeks without decreasing in diagnostic accuracy con-
cerning HPV detection [47]. All of these factors are cru-
cial when exploring the performance of self-sampling in
a rural African health care setting.
Each FGD (and KII) was conducted in Amharic and
lasted 60–90min. They were audio-recorded after hav-
ing obtained written informed consent and notes were
taken both on verbal and non-verbal communication.
In order to avoid intimidation by hierarchical struc-
tures and to allow free and open discussion among the
participants, the groups were formed homogenously in
terms of their socio-economic status in the community.
FGD participants sat in a circle and introduced them-
selves anonymously using code names which were used
for reference during the discussions, as well as in all
transcripts and notes associated. However, there is no
absolute certainty that all participants were complete
strangers to each other. The two facilitators enabled a
free and open atmosphere for discussion and encouraged
the women to actively participate at all times throughout
the discussion.
A male senior resident of the Obstetrics and Gynae-
cology department at Gondar University Hospital
assisted in the conduct of the interviews and helped with
emerging medical questions. He introduced and ex-
plained the self-sampling device, as well as the exact
screening procedure to the participants. In detail, a dem-
onstration video on how to use the Evalyn® Brush (trans-
lated into Amharic) was shown to the participants.
Furthermore, an exemplary brush was demonstrated and
the self-collection procedure was explained a second
time. Then the brushes were passed around to allow
each woman to get a physical impression of the device.
Data analysis
The two qualitative data collection experts transcribed
all audio-recordings and field notes into Amharic and
translated them into English. The datasets were analysed
through thematic analysis.
Themes and sub-categories were induced from the tran-
scripts through repeated reading. Majoritarian key mes-
sages, attitudes, perceptions and thoughts with particular
emerging concepts were identified and coded. Responses
from individual participants were put into sub-categories
and broken down into units of sentences and paragraphs
that represented particular thoughts of participants. Re-
peated ideas were categorized into broader themes
(groups of repeated ideas) in order to create a theoretical
narrative. Once themes and sub-categories were estab-
lished, the transcripts were re-read to ensure they appro-
priately reflected the content of the data. Themes were
then compared between FGD groups to identify similar-
ities and differences. The qualitative data serves as prior
research about the target community in relation to the ap-
plication of a theoretical framework like the Health Belief
Model for behaviour change [48, 49].
Results
Participants characteristics
Of the 41 women participating in the community
focus group discussions, the average age was 29 years
with a range between 20 and 38 years. The majority
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of women had attended primary school with or with-
out some secondary education (41.5%) and 24.4%
were illiterate or only experienced some primary
schooling (see Additional file 3: Table S3).
All participants engaged well in the discussions. We
present a summary of repeated ideas with selected repre-
sentative quotes of the thematic areas explored.
Thoughts on cervical cancer and its origin
Due to a lack of knowledge about cancer in general, as
well as cervical cancer specifically, FGD participants -
with and without medical background - could only make
assumptions about possible signs and symptoms of cer-
vical cancer. They are aware of many commonly known,
however, unspecific gynaecological symptoms like pain,
swelling, itching, burning and bleeding of the genital
organ, as well as constant foul-smelling discharge. The
clinic nurses were more precise in naming pathogno-
monic signs, risk factors and causes of cervical cancer,
however only one of nine nurses mentioned the Human
Papillomavirus (HPV) as causative factor and even
among nurses and HDAL mainly cultural and traditional
beliefs were reported when asked about the causes of
cancer. One notably interesting aspect brought up con-
sistently in all four FGDs was something called “Mitat/
Girefat” in the local language. This means that “sudden
exposure of the body to sunlight” – particularly while
menstruating – “sitting on hot surfaces” and “urinating
on hot ground” is thought to be the cause of many health
problems. It is believed that urine evaporates once it hits
the hot ground outside and the “evaporated gas from the
surface will carry disease causing agents to the inside (of )
the body”. ‘Girefat’ is a traditional concept for the patho-
genesis of several diseases including sexually transmitted
diseases [50, 51].
Sequels of the development of symptoms
According to FGD participants, women affected by
symptoms perceived as caused by cervical cancer would
“face stigma and discrimination” by friends, neighbours
and eventually even family members and marital part-
ners leading to hopelessness and despair for the affected
women. This was a particularly interesting aspect, as the
fear of the social implications due to these signs and
symptoms of a disease supposedly perceived as cervical
cancer clearly outweighed the women’s fear of premature
death connoted with cancer.
The unfamiliarity of a screening concept
Despite the brutal prospects of falling ill as a member of
the community, the large majority of women did neither
know about the existence of cervical cancer prevention,
nor would they necessarily seek it far in advance. The
concept of screening – being examined for a disease that
they do not yet suffer from but might in the future – is
unfamiliar to them. Most people do not seek care unless
they are already experiencing severe symptoms. Being
able to fulfil their daily tasks and duties as farmers or
housewives is much more important than worrying
about their future health. A 26-year old community
member said: “In our community medical check-ups and
early treatment seeking practices are no well-known is-
sues. Even literate community members will not go to
health facilities until the problem reaches a severe level.”
Moreover, in the key informant interviews with a
female midwife, female community health extension
worker, as well as the male health official it became clear
that screening is currently not offered in this health
centre due to lack of facilities and equipment, even
though local health professionals had previously been
trained in providing the service. As there was no screen-
ing opportunity available, women of the community
currently have low awareness nor previous screening
experience. However, the midwife key informant stated:
“If the community (was) well aware about the disease
they will have (an) interest to get the service.”
Barriers not to use preventive health services – fear
While further discussing preventive medical services, the
topic of fear was brought up: Fear of needing expensive
diagnostic work-up and treatment resulting in over-
whelming financial charges. But furthermore, fear of
being diagnosed with a disease with no treatment option
available in their closer surroundings – regardless of
finances – and consequently becoming an outcast of
their community due to their diagnosis “If there is no
treatment after the examination, people will not want to
be screened for cervical cancer.”, said a 21-year old
woman attending the health centre. This illustrates the
perceived limited access to existing local, as well as
national health services of remote and rural communi-
ties that might be derived from past experiences.
Ease of use – the Evalyn® brush
After presentation of the self-collection procedure with
the Evalyn® Brush the women throughout all four focus
groups were positively impressed and confident to be
able to perform the “task” of self-sampling after obtain-
ing clear oral instructions. They were happy to see a
simple device that will help them preserve their health
for the future and bring health promotion from central-
ized and distant health centres closer into their commu-
nity, making it more accessible for them.
However, one (26-year old) HDA leader was worried
that women might blame the device in case they end up
experiencing any gynaecological issues, as it “touch(es)
(…) sensitive area(s) of (the female) reproductive or-
gan(s)”. It was mentioned as an example that in the past
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Norplant® implanted for contraceptive purposes was
made responsible for unrelated issues.
When asked about the place where to best implement
the screening practice, perceptions among women of the
community and women involved with health services
were equally divided. Women who preferred home-
based self-sampling listed advantages like alleviation of
shame through privacy of their own house and increase
in screening participation by overcoming some women’s
inability to travel to the health centre, while on the other
hand, women who preferred the health post or health
centre for screening brought forward arguments like lack
of hygiene at home with potential risk of contaminating
the device, inability to bring the device back to the
health centre, lacking medical proficiency to perform the
“task” and lack of privacy at home.
Based on arguments of both sides, the focus groups
agreed on the ability to perform self-sampling on the
household level if women in the community were
trained well in the performance of the procedure and
mentored by local health professionals. However, the
option of performing it at a local health post should be
granted.
Spousal permission – crucial barrier for HPV self-sampling
When probed about barriers for the implementation of
community home-based HPV self-sampling, the over-
whelming majority of women mentioned their spousal’s
permission. As long as their marital partners were
informed about the device and the exact procedure, the
women would be granted unrestricted permission to
undergo screening. Otherwise, they might associate the
device with “forbidden sexual relation(s)”.
This patriarchal aspect of the Ethiopian societal system
was confirmed by two male participants of the KIIs (see
Additional file 2: Table S2). From their viewpoint, spou-
sal permission is crucial and husbands should be well
informed about the device in order to avoid enormous
barriers for the women to harness this medical prevent-
ive service.
Therefore, it was strongly recommended by everyone
throughout all FGDs and KIIs to create awareness,
knowledge and education in the community about the
disease cervical cancer, the self-sampling device itself
and the associated opportunity of “task shifting” cervical
cancer prevention directly into the community. This
would simplify the implementation of a screening
program comprising home-based HPV self-sampling
tremendously.
Discussion
HPV self-sampling is a promising tool to foster women’s
health autonomy and to potentially widen cervical can-
cer screening coverage also to remote settings by shifting
the sampling procedure to the community. Our study is
the first to explore acceptability and barriers for home-
based HPV self-sampling in a rural Ethiopian commu-
nity with limited access to health services and naïve to
screening practices.
Previous studies have shown that a multi-fold of
women can be mobilized using self-sampling methods
for cervical cancer screening in women all around the
world [21–33, 52–55]. However, most studies are biased
by recruiting mainly screening-experienced and inter-
ested women during a routine clinic visit or by inviting
them to come to the health clinics to collect a sample
themselves [33, 34]. This approach may exclude participa-
tion of hard-to-reach women who are already reluctant to
attend medical services due to the logistical burden and
expenditure of time that is entailed [20, 23, 29, 30]. In
Europe, screening non-attendees were reached by
mailing self-sampling kits to their home, however,
these women have already had previous experiences
with well-working health services and cervical cancer
screening [21, 22, 24–27, 53]. Our study identified
important themes to be considered when implement-
ing home-based self-sampling in rural Ethiopia or
similar settings.
Awareness-building is key
A main concern is the lack of knowledge regarding can-
cer and cancer prevention. This was previously con-
firmed in studies by Birhanu et al., Getahun et al. and
Mitiku et al. Despite it being proclaimed a health prior-
ity of the Ethiopian government [56] knowledge and
awareness about cervical cancer is low in Ethiopian
communities [48, 57, 58]. Several informants confirmed
the existence of a traditional belief called “mitat” mean-
ing ‘sudden exposure of the body to sunlight’ which is
associated with the occurrence of cervical cancer.
In the absence of a clear concept of cancer most par-
ticipants linked cancer manifestations with those of
other major gynaecological diseases such as gynaeco-
logical fistula, prolapse and infections and emphasised
the risk of social rejection, discrimination and stigma in
severe cases. Education about women’s health problems
thus seems to be an important component of cervical
cancer awareness in order to make informed choices.
Education furthermore has the potential to mitigate
feelings of “embarrassment”, “shame” and “fear”, im-
portant barriers for women to refrain from a preventive
gynaecological examination as shown in Western com-
munities [59–62], as well as in communities in Zambia
and Uganda [63, 64]. White at al. showed that these
psychosocial barriers were the most modifiable of all
barriers as they are “dynamic” rather than “static” emo-
tions because they decreased over time once women
were educated about cervical cancer – especially about
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the fact of early detection, slow progression and treat-
ability [64]. In a study by Crofts et al. teaching 540
women in Cameroon about the Human Papillomavirus
and cervical cancer achieved higher acceptance of HPV
self-sampling and a decrease in embarrassment, anxiety
and discomfort [35]. Teng et al. noted that the overcom-
ing of these psychosocial barriers might have even
greater benefit for the uptake of screening than the im-
mediate abolition of socio-economic, financial or logis-
tical barriers [63].
Increasing women’s confidence
Initially participants were concerned regarding their
ability to perform the test correctly [43, 62, 65–67].
However, explaining the procedure using a ‘demonstra-
tion brush’ and a description video assured the partici-
pants about their capability to perform self-sampling.
Hanley et al. provided 200 eligible Japanese women of
which merely 22.7% had previous experience with tam-
pon use with just written and pictorial instructions on a
self-sampling kit [43]. Nevertheless, 96.9% had no
trouble comprehending the instructions. Some of the
participating women were unconfident that the test was
administered correctly in comparison to a physician-col-
lected sample, while in reality no invalid samples were
submitted. Similar findings were reported in a study by
Vanderpool et al. in a population of rural Appalachian
women [68] and by Sewali et al. in a population of
Somali immigrants in the US [69]. It hints at findings of
the previously mentioned study by Crofts et al. in
Cameroon where through prior education 90% of
women were confident to have performed self-sampling
correctly and 96.7% found it easy to perform [35].
Provision of instructions appropriate to each study
population (literate or illiterate) and information on the
accuracy on HPV self-sampling will increase women’s
confidence in their ability to perform the test correctly
[70]. This also confirms findings of other studies in
several female African populations showing that women
are indeed willing to collect their own cervical samples
and that self-sampling methods are socially acceptable
and possibly even more feasible than other screening
methods like Pap cytology or visual inspection with
acetic acid (VIA) [71–73].
Including the family
Crucial family members – especially the women’s hus-
bands – need to be informed and involved in the process
in order to avoid mistrust and misunderstanding. Our
findings show that – if well informed – they will endorse
their spouse to test, preserve and improve their health
status. They were also accepting the self-sampling device
as long as confidentiality and privacy of the woman are
ensured to prevent stigma and discrimination. Likewise,
Mutyaba et al. determined they are “potential willing
partners” in improving women’s and maternal health
[74]. Sewali et al., moreover assessed that women having
friends or family members with whom to discuss cancer
screening were three times more likely to participate in
any screening test than those who do not [69].
Importance of care continuum
The concept of secondary prevention, especially the fact
that supposedly “healthy” persons have to undergo a
medical test, was unknown to most community partici-
pants. In order to promote “task shifting” of cervical
cancer screening in the communities, explanation of the
screening aim to early detect precancerous lesions and
the slow progression and high potential of cure of these
lesions are an important part of the information pack-
age. Women further stated the importance to be assured
about treatment availability in their surroundings to
raise credibility, reliability and trust in the local health
services. We found consensus in all four FGDs regarding
the potential role of the existing health network (CHEW
and HDAL) in promoting, disseminating and performing
home-based self-sampling as part of the WHO’s “task
shifting project” either in the home or when preferred in
the health post. The study is an important activity to
prepare a community-wide HPV-based screening and
treatment campaign in the region as it is a major un-
certainty whether self-sampling on the household level
would be acceptable.
Limitations
As the study findings are based only on small samples,
they may not be generalizable within Ethiopia, let alone
the whole sub-Saharan African region due to socio-cul-
tural differences between regions and countries. Further-
more, the research team was limited in its ability to
explore the perspective of all ethnic groups within the
target community.
Some questions posed to the groups were necessarily
speculative in nature, since the proposed program does
not yet exist; it is therefore difficult to predict reactions
to a program once it is implemented.
Conclusion
Home-based self-sampling for cervical cancer screening
is a socially acceptable and feasible “task shifting”
method that could increase cervical cancer screening
access and coverage in the Ethiopian study community.
Education, community mobilization, awareness creation
and family inclusion are identified as key activities to
promote, implement and facilitate self-sampling in rural
and low-resource African communities. Already existing
social networks, for instance religious communities, and
peer-to-peer education could be useful in passing down
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information on health-related topics, including HPV
self-sampling and increasing women’s confidence in
being able to perform this “task”. Husbands and other
crucial family members play key roles in women’s health
behaviour and therefore must be involved early in order
to avoid mistrust.
Additional files
Additional file 1: Table S1. Distribution of participants in community
Focus Group Discussions (FGD). (DOCX 47 kb)
Additional file 2: Table S2. Key Informant Interview (KII) Participants.
(DOCX 43 kb)
Additional file 3: Table S3. Characteristics of Focus Group Discussion
participants (DOCX 46 kb)
Additional file 4: English language copy of the Interview and FGD
Guides used as supplementary files. (PDF 396 kb)
Abbreviations
(hr)HPV: High-risk-type Human papillomavirus; CHEW: Community health
extension worker; FGD: Focus group discussion; HDAL: Health development
army leader; HIV: Human Immunodeficiency Virus; HPV: Human
papillomavirus; IRB: Institutional Review Board; KII: Key informant interview;
LMIC: Low- and middle-income countries; OGAC: Office of the United States
Global AIDS Coordinator; VIA: Visual inspection with acetic acid;; WHO: World
Health Organization
Acknowledgements
We acknowledge financial support by the German Research Foundation
(Deutsche Forschungsgemeinschaft) within the funding programme Open
Access Publishing, by the Baden-Württemberg Ministry of Science, Research
and the Arts and by Ruprecht-Karls-Universität Heidelberg.
Authors’ contributions
TB organised and oversaw the conduct of the focus group discussions and
key informant interviews, analysed and interpreted the qualitative data and
was the major contributor in writing the manuscript. SBW, SH, GD organized,
conducted and moderated the discussions, transcribed the audio files and
translated from Amharic into English and vice versa. YA and KA made
substantial contributions to conception, design and translation of the focus
group topic guide and informed consent form and translated from Amharic
into English and vice versa. HB made substantial contributions to the
conception of the study, data analysis, as well as drafting the manuscript and
revising it critically for important intellectual content. FJ and MKD were
contributors in drafting and revising the manuscript. All authors contributed
to revisions of the manuscript, have read and approved of the final version
of the manuscript, participated in the decision to submit and had full access
to all of the data in the study.
Funding
The University of Heidelberg, Germany, supplied the financial budget for the
purchase of Rover Evalyn® Brushes, travel expenses, as well as
accommodation in Ethiopia. The manufacturer of the Evalyn Brush, Rovers,
Oss, The Netherlands, had no part in the study.
Availability of data and materials
The datasets generated and analysed during the current study are not
publicly available due to possible inclusion of identifying confidential
personal data but are available from the corresponding author on
reasonable request.
Ethics approval and consent to participate
Research was performed in accordance with the Declaration of Helsinki.
Ethical approval was obtained from the Institutional Review Board (IRB) of
the University of Gondar (O/V/P/RCS/05/107/2016; 19.10.16), as well as the
IRB at Heidelberg University School of Medicine, Germany (S-636/2016;
05.12.16). All participants were provided with information about the study,
were willing to participate and signed an Informed Consent Form in
Amharic prior to the conduct of the interviews.
Consent for publication
All participants were provided with information about the study, were
willing to participate, approved of the use and publication of data acquired
and signed an Informed Consent Form in Amharic prior to the conduct of
the interview.
Competing interests
The authors declare that they have no competing interests.
Author details
1Department of Applied Tumor Biology, Institute of Pathology, Heidelberg
University Hospital, Im Neuenheimer Feld 224, 69120 Heidelberg, Germany.
2Department of Gynaecology, School of Medicine, College of Medicine and
Health Sciences, University of Gondar, Gondar, Ethiopia. 3Institute of Public
Health, College of Medicine and Health Sciences, University of Gondar,
Gondar, Ethiopia. 4Dabat Research Centre Health and Demographic
Surveillance System, Institute of Public Health, College of Medicine and
Health Sciences, University of Gondar, Gondar, Ethiopia.
Received: 20 August 2018 Accepted: 22 July 2019
References
1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al.
Cancer incidence and mortality worldwide: sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.
2. Arbyn M, Raifu AO, Weiderpass E, Bray F, Anttila A. Trends of cervical cancer
mortality in the member states of the European Union. Eur J Cancer
(Oxford, England : 1990). 2009;45(15):2640–8.
3. Bray F, Loos AH, McCarron P, Weiderpass E, Arbyn M, Moller H, et al. Trends
in cervical squamous cell carcinoma incidence in 13 European countries:
changing risk and the effects of screening. Cancer Epidemiol Biomark Prev.
2005;14(3):677–86.
4. Levi F, Lucchini F, Negri E, Franceschi S, la Vecchia C. Cervical cancer
mortality in young women in Europe: patterns and trends. Eur J Cancer
(Oxford, England : 1990). 2000;36(17):2266–71.
5. Kaindjee-Tjituka F, Sawadogo S, Mutandi G, Maher AD, Salomo N, Mbapaha
C, et al. Task-shifting point-of-care CD4+ testing to lay health workers in HIV
care and treatment services in Namibia. Afr J Lab Med. 2017;6(1):643.
6. Kiweewa FM, Wabwire D, Nakibuuka J, Mubiru M, Bagenda D, Musoke
P, et al. Noninferiority of a task-shifting HIV care and treatment model
using peer counselors and nurses among Ugandan women initiated on
ART: evidence from a randomized trial. J Acquir Immune Defic Syndr.
2013;63(4):e125–32.
7. Boulle C, Kouanfack C, Laborde-Balen G, Carrieri MP, Dontsop M, Boyer S, et
al. Task shifting HIV care in rural district hospitals in Cameroon: evidence of
comparable antiretroviral treatment-related outcomes between nurses and
physicians in the Stratall ANRS/ESTHER trial. J Acquir Immune Defic Syndr.
2013;62(5):569–76.
8. Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A,
et al. Human papillomavirus DNA versus Papanicolaou screening tests for
cervical cancer. N Engl J Med. 2007;357(16):1579–88.
9. Naucler P, Ryd W, Tornberg S, Strand A, Wadell G, Elfgren K, et al. Efficacy of
HPV DNA testing with cytology triage and/or repeat HPV DNA testing in
primary cervical cancer screening. J Natl Cancer Inst. 2009;101(2):88–99.
10. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human
papillomavirus and cervical cancer. Lancet. 2007;370(9590):890–907.
11. Castle PE, Stoler MH, Wright TC Jr, Sharma A, Wright TL, Behrens CM.
Performance of carcinogenic human papillomavirus (HPV) testing and
HPV16 or HPV18 genotyping for cervical cancer screening of women aged
25 years and older: a subanalysis of the ATHENA study. Lancet Oncol.
2011;12(9):880–90.
12. Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, et al.
Worldwide distribution of human papillomavirus types in cytologically
normal women in the International Agency for Research on Cancer HPV
prevalence surveys: a pooled analysis. Lancet. 2005;366(9490):991–8.
Brandt et al. BMC Public Health         (2019) 19:1026 Page 7 of 9
13. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et
al. Human papillomavirus is a necessary cause of invasive cervical cancer
worldwide. J Pathol. 1999;189(1):12–9.
14. Bulkmans NW, Berkhof J, Rozendaal L, van Kemenade FJ, Boeke AJ,
Bulk S, et al. Human papillomavirus DNA testing for the detection of
cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up
of a randomised controlled implementation trial. Lancet. 2007;
370(9601):1764–72.
15. Ronco G, Dillner J, Elfstrom KM, Tunesi S, Snijders PJ, Arbyn M, et al.
Efficacy of HPV-based screening for prevention of invasive cervical
cancer: follow-up of four European randomised controlled trials. Lancet.
2014;383(9916):524–32.
16. Arbyn M, Verdoodt F, Snijders PJ, Verhoef VM, Suonio E, Dillner L, et al.
Accuracy of human papillomavirus testing on self-collected versus clinician-
collected samples: a meta-analysis. Lancet Oncol. 2014;15(2):172–83.
17. Ketelaars PJW, Bosgraaf RP, Siebers AG, Massuger L, van der Linden JC,
Wauters CAP, et al. High-risk human papillomavirus detection in self-
sampling compared to physician-taken smear in a responder population
of the Dutch cervical screening: results of the VERA study. Prev Med.
2017;101:96–101.
18. Zhao FH, Lewkowitz AK, Chen F, Lin MJ, Hu SY, Zhang X, et al. Pooled
analysis of a self-sampling HPV DNA test as a cervical cancer primary
screening method. J Natl Cancer Inst. 2012;104(3):178–88.
19. Bhatla N, Dar L, Patro AR, Kumar P, Kriplani A, Gulati A, et al. Can human
papillomavirus DNA testing of self-collected vaginal samples compare with
physician-collected cervical samples and cytology for cervical cancer
screening in developing countries? Cancer Epidemiol. 2009;33(6):446–50.
20. Arbyn M, Smith SB, Temin S, Sultana F, Castle P. Detecting cervical
precancer and reaching underscreened women by using HPV testing on
self samples: updated meta-analyses. Bmj. 2018;363:k4823.
21. Gok M, Heideman DA, van Kemenade FJ, Berkhof J, Rozendaal L, Spruyt JW,
et al. HPV testing on self collected cervicovaginal lavage specimens as
screening method for women who do not attend cervical screening: cohort
study. BMJ. 2010;340:c1040.
22. Virtanen A, Anttila A, Luostarinen T, Nieminen P. Self-sampling versus
reminder letter: effects on cervical cancer screening attendance and
coverage in Finland. Int J Cancer. 2011;128(11):2681–7.
23. Catarino R Jr, Vassilakos P, Stadali-Ullrich H, Royannez-Drevard I, Guillot
C, Petignat P. Feasibility of at-home self-sampling for HPV testing as an
appropriate screening strategy for nonparticipants in Switzerland:
preliminary results of the DEPIST study. J Low Genit Tract Dis. 2015;
19(1):27–34.
24. Enerly E, Bonde J, Schee K, Pedersen H, Lonnberg S, Nygard M. Self-
sampling for human papillomavirus testing among non-attenders increases
attendance to the Norwegian cervical Cancer screening Programme. PLoS
One. 2016;11(4):e0151978.
25. Lam, JU, Rebolj M, Moller Ejegod D, Pedersen H, Rygaard C, Lynge E,
Thirstrup Thomsen L, Kruger Kjaer S, Bonde J, et al. Human papillomavirus
self-sampling for screening nonattenders: opt-in pilot implementation with
electronic communication platforms. Int J Cancer. 2017;140(10):2212–9.
26. Cadman L, Wilkes S, Mansour D, Austin J, Ashdown-Barr L, Edwards R, et al.
A randomized controlled trial in non-responders from Newcastle upon Tyne
invited to return a self-sample for human papillomavirus testing versus
repeat invitation for cervical screening. J Med Screen. 2015;22(1):28–37.
27. Darlin L, Borgfeldt C, Forslund O, Henic E, Dillner J, Kannisto P. Vaginal self-
sampling without preservative for human papillomavirus testing shows
good sensitivity. J Clin Virol. 2013;56(1):52–6.
28. Ogilvie GS, Mitchell S, Sekikubo M, Biryabarema C, Byamugisha J, Jeronimo
J, et al. Results of a community-based cervical cancer screening pilot project
using human papillomavirus self-sampling in Kampala, Uganda. Int J
Gynaecol Obstet. 2013;122(2):118–23.
29. Bansil P, Wittet S, Lim JL, Winkler JL, Paul P, Jeronimo J. Acceptability of self-
collection sampling for HPV-DNA testing in low-resource settings: a mixed
methods approach. BMC Public Health. 2014;14:596.
30. Rosenbaum AJ, Gage JC, Alfaro KM, Ditzian LR, Maza M, Scarinci IC, et al.
Acceptability of self-collected versus provider-collected sampling for HPV
DNA testing among women in rural El Salvador. Int J Gynaecol Obstet.
2014;126(2):156–60.
31. Arrossi S, Thouyaret L, Herrero R, Campanera A, Magdaleno A, Cuberli M, et
al. Effect of self-collection of HPV DNA offered by community health
workers at home visits on uptake of screening for cervical cancer (the EMA
study): a population-based cluster-randomised trial. Lancet Glob Health.
2015;3(2):e85–94.
32. Moses E, Pedersen HN, Mitchell SM, Sekikubo M, Mwesigwa D, Singer J, et
al. Uptake of community-based, self-collected HPV testing vs. visual
inspection with acetic acid for cervical cancer screening in Kampala,
Uganda: preliminary results of a randomised controlled trial. Tropical Med
Int Health. 2015;20(10):1355–67.
33. Modibbo F, Iregbu KC, Okuma J, Leeman A, Kasius A, de Koning M, et al.
Randomized trial evaluating self-sampling for HPV DNA based tests for
cervical cancer screening in Nigeria. Infect Agent Cancer. 2017;12:11.
34. Broquet C, Triboullier D, Untiet S, Schafer S, Petignat P, Vassilakos P.
Acceptability of self-collected vaginal samples for HPV testing in an urban
and rural population of Madagascar. Afr Health Sci. 2015;15(3):755–61.
35. Crofts V, Flahault E, Tebeu PM, Untiet S, Fosso GK, Boulvain M, et al.
Education efforts may contribute to wider acceptance of human
papillomavirus self-sampling. Int J Women's Health. 2015;7:149–54.
36. Allen-Leigh B, Uribe-Zuniga P, Leon-Maldonado L, Brown BJ, Lorincz A,
Salmeron J, et al. Barriers to HPV self-sampling and cytology among low-
income indigenous women in rural areas of a middle-income setting: a
qualitative study. BMC Cancer. 2017;17(1):734.
37. Racey CS, Gesink DC. Barriers and facilitators to cervical Cancer screening
among women in rural Ontario, Canada: the role of self-collected HPV
testing. J Rural Health. 2016;32(2):136–45.
38. Waktola EA, Mihret W, Bekele L. HPV and burden of cervical cancer in East
Africa. Gynecol Oncol. 2005;99(3 Suppl 1):S201–2.
39. Bruni L, Barrionuevo-Rosas, L., Albero, G., Serrano, B., Mena, M., Gómez, D.,
Munoz, J., Bosch, FX., de Sanjosé, S. Human Papillomavirus and Related
Diseases in Ethiopia. Summary Report. ICO Information Centre on HPV and
Cancer (HPV Information Centre); 2017 27.07.2017.
40. Stalmeijer RE, McNaughton N, Van Mook WN. Using focus groups in
medical education research: AMEE guide no. 91. Med Teach. 2014;
36(11):923–39.
41. Barbour R. Doing focus groups. 2nd ed. Thousand Oaks: SAGE Publications;
2017. pages cm p
42. van Baars R, Bosgraaf RP, ter Harmsel BW, Melchers WJ, Quint WG, Bekkers
RL. Dry storage and transport of a cervicovaginal self-sample by use of the
Evalyn brush, providing reliable human papillomavirus detection combined
with comfort for women. J Clin Microbiol. 2012;50(12):3937–43.
43. Hanley SJ, Fujita H, Yokoyama S, Kunisawa S, Tamakoshi A, Dong P, et al.
HPV self-sampling in Japanese women: a feasibility study in a population
with limited experience of tampon use. J Med Screen. 2016;23(3):164–70.
44. Leinonen MK, Schee K, Jonassen CM, Lie AK, Nystrand CF, Rangberg A, et al.
Safety and acceptability of human papillomavirus testing of self-collected
specimens: A methodologic study of the impact of collection devices and
HPV assays on sensitivity for cervical cancer and high-grade lesions. J Clin
Virol. 2018;99–100:22–30.
45. Chen K, Ouyang Y, Hillemanns P, Jentschke M. Excellent analytical and
clinical performance of a dry self-sampling device for human papillomavirus
detection in an urban Chinese referral population. J Obstet Gynaecol Res.
2016;42(12):1839–45.
46. Othman NH, Zaki FH, Hussain NH, Yusoff WZ, Ismail P. SelfSampling versus
Physicians’ sampling for cervical Cancer screening agreement of cytological
diagnoses. Asian Pac J Cancer Prev. 2016;17(7):3489–94.
47. Ejegod DM, Pedersen H, Alzua GP, Pedersen C, Bonde J. Time and
temperature dependent analytical stability of dry-collected Evalyn HPV
self-sampling brush for cervical cancer screening. Papillomavirus Res.
2018;5:192–200.
48. Birhanu Z, Abdissa A, Belachew T, Deribew A, Segni H, Tsu V, et al. Health
seeking behavior for cervical cancer in Ethiopia: a qualitative study. Int J
Equity Health. 2012;11:83.
49. Champion VL, Skinner CS. The Health Belief Model. In: Glanz K, Rimer BK,
Viswanath K, editors. Health Behavior and Health Education: Theory,
Research, and Practice. 4th ed. San Francisco: Jossey Bass; 2008.
50. Teshome-Bahiru W. Concept of health, disease, Illnes and therapy among
the people of Addis Ababa. Ann Afr Med. 2004;3(1):28–31.
51. Gebre A. Community knowledge and perceptions about HIV/AIDS and
other sexually transmitted diseases in Bahir Dar. Northeast Afr Stud New Ser
Spec Issue: HIV/AIDS Ethiop Part I: Risk Prev Behav Sex Opportunistic Infect.
2000;7(1):127–46 (20 pages).
52. Verdoodt F, Jentschke M, Hillemanns P, Racey CS, Snijders PJ, Arbyn M.
Reaching women who do not participate in the regular cervical cancer
Brandt et al. BMC Public Health         (2019) 19:1026 Page 8 of 9
screening programme by offering self-sampling kits: a systematic review
and meta-analysis of randomised trials. Eur J Cancer (Oxford, England :
1990). 2015;51(16):2375–85.
53. Racey CS, Gesink DC, Burchell AN, Trivers S, Wong T, Rebbapragada A.
Randomized intervention of self-collected sampling for human
papillomavirus testing in under-screened rural women: uptake of screening
and acceptability. J Women's Health (Larchmt). 2016;25(5):489–97.
54. Mandigo M, Frett B, Laurent JR, Bishop I, Raymondville M, Marsh S, et
al. Pairing community health workers with HPV self-sampling for
cervical cancer prevention in rural Haiti. Int J Gynaecol Obstet. 2015;
128(3):206–10.
55. Snijders PJ, Verhoef VM, Arbyn M, Ogilvie G, Minozzi S, Banzi R, et al. High-
risk HPV testing on self-sampled versus clinician-collected specimens: a
review on the clinical accuracy and impact on population attendance in
cervical cancer screening. Int J Cancer. 2013;132(10):2223–36.
56. Federal Ministry of Health E. In: DPaC D, editor. National Cancer Control
Plan 2016–2020: Federal Ministry of Health Ethiopia; 2015. https://www.iccp-
portal.org/sites/default/files/plans/NCCP%20Ethiopia%20Final%20261015.pdf.
57. Getahun F, Mazengia F, Abuhay M, Birhanu Z. Comprehensive knowledge
about cervical cancer is low among women in Northwest Ethiopia. BMC
Cancer. 2013;13:2.
58. Mitiku I, Tefera F. Knowledge about cervical Cancer and associated factors
among 15-49 year old women in Dessie town, Northeast Ethiopia. PLoS
One. 2016;11(9):e0163136.
59. Waller J, Bartoszek M, Marlow L, Wardle J. Barriers to cervical cancer
screening attendance in England: a population-based survey. J Med Screen.
2009;16(4):199–204.
60. Virtanen A, Nieminen P, Niironen M, Luostarinen T, Anttila A. Self-sampling
experiences among non-attendees to cervical screening. Gynecol Oncol.
2014;135(3):487–94.
61. Bosgraaf RP, Ketelaars PJ, Verhoef VM, Massuger LF, Meijer CJ, Melchers WJ,
et al. Reasons for non-attendance to cervical screening and preferences for
HPV self-sampling in Dutch women. Prev Med. 2014;64:108–13.
62. Szarewski A, Cadman L, Ashdown-Barr L, Waller J. Exploring the
acceptability of two self-sampling devices for human papillomavirus testing
in the cervical screening context: a qualitative study of Muslim women in
London. J Med Screen. 2009;16(4):193–8.
63. Teng FF, Mitchell SM, Sekikubo M, Biryabarema C, Byamugisha JK, Steinberg
M, et al. Understanding the role of embarrassment in gynaecological
screening: a qualitative study from the ASPIRE cervical cancer screening
project in Uganda. BMJ Open. 2014;4(4):e004783.
64. White HL, Mulambia C, Sinkala M, Mwanahamuntu MH, Parham GP,
Moneyham L, et al. ‘Worse than HIV’ or ‘not as serious as other diseases’?
Conceptualization of cervical cancer among newly screened women in
Zambia. Soc Sci Med. 2012;74(10):1486–93.
65. Howard M, Lytwyn A, Lohfeld L, Redwood-Campbell L, Fowler N, Karwalajtys T.
Barriers to acceptance of self-sampling for human papillomavirus across
ethnolinguistic groups of women. Can J Public Health. 2009;100(5):365–9.
66. Barata PC, Mai V, Howlett R, Gagliardi AR, Stewart DE. Discussions about self-
obtained samples for HPV testing as an alternative for cervical cancer
prevention. J Psychosom Obstet Gynaecol. 2008;29(4):251–7.
67. Waller J, McCaffery K, Forrest S, Szarewski A, Cadman L, Austin J, et al.
Acceptability of unsupervised HPV self-sampling using written instructions. J
Med Screen. 2006;13(4):208–13.
68. Vanderpool RC, Jones MG, Stradtman LR, Smith JS, Crosby RA. Self-
collecting a cervico-vaginal specimen for cervical cancer screening: an
exploratory study of acceptability among medically underserved women in
rural Appalachia. Gynecol Oncol. 2014;132(Suppl 1):S21–5.
69. Sewali B, Okuyemi KS, Askhir A, Belinson J, Vogel RI, Joseph A, et al. Cervical
cancer screening with clinic-based pap test versus home HPV test among
Somali immigrant women in Minnesota: a pilot randomized controlled trial.
Cancer Med. 2015;4(4):620–31.
70. Berner A, Hassel SB, Tebeu PM, Untiet S, Kengne-Fosso G, Navarria I, et al.
Human papillomavirus self-sampling in Cameroon: women's uncertainties
over the reliability of the method are barriers to acceptance. J Low Genit
Tract Dis. 2013;17(3):235–41.
71. Podolak I, Kisia C, Omosa-Manyonyi G, Cosby J. Using a multimethod
approach to develop implementation strategies for a cervical self-sampling
program in Kenya. BMC Health Serv Res. 2017;17(1):222.
72. Rositch AF, Gatuguta A, Choi RY, Guthrie BL, Mackelprang RD, Bosire
R, et al. Knowledge and acceptability of pap smears, self-sampling
and HPV vaccination among adult women in Kenya. PLoS One. 2012;
7(7):e40766.
73. Jones HE, Brudney K, Sawo DJ, Lantigua R, Westhoff CL. The acceptability of
a self-lavaging device compared to pelvic examination for cervical cancer
screening among low-income women. J Women's Health (Larchmt). 2012;
21(12):1275–81.
74. Mutyaba T, Faxelid E, Mirembe F, Weiderpass E. Influences on uptake of
reproductive health services in Nsangi community of Uganda and their
implications for cervical cancer screening. Reprod Health. 2007;4:4.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Brandt et al. BMC Public Health         (2019) 19:1026 Page 9 of 9
